Medication-Assisted Treatment for opioid use disorder.
MAT is the clinical standard of care for opioid use disorder. Suboxone, Subutex, and Vivitrol are all part of our program, delivered under a clinician's care from your first day of treatment.
Most major commercial insurance plans cover MAT.
Suboxone, Subutex, and Vivitrol are typically covered by commercial insurance for opioid use disorder. Call admissions and we'll verify your specific plan, formulation, and pharmacy benefit details as part of that first conversation.
Medications we offer.
Suboxone
Buprenorphine + naloxone. Office-based daily sublingual dosing. Partial agonist with built-in misuse deterrent.
Learn more about Suboxone →Subutex
Buprenorphine alone. Used during pregnancy when the naloxone in Suboxone isn't appropriate.
Learn more about Subutex →Vivitrol
Extended-release naltrexone. Monthly injection. Requires 7–14 days opioid-free before the first dose.
Learn more about Vivitrol →Common questions about MAT.
Will my insurance cover MAT?
Hickory Grove works with commercial insurance for MAT for opioid use disorder. Our admissions team verifies your specific plan and pharmacy benefit details as part of that first conversation.
Which MAT is right for me?
It depends on overdose risk, prior treatment history, pregnancy status, and personal preference. A Hickory Grove clinician will help you choose during the assessment.
Can I do MAT during pregnancy?
Yes. Subutex (buprenorphine alone, without naloxone) is the standard MAT for pregnant patients with OUD — naloxone, the second ingredient in Suboxone, is contraindicated in pregnancy.
How long should I stay on MAT?
MAT is meant to be a long-term treatment for many patients. There is no clinical evidence that shorter MAT duration improves outcomes. Tapering, when appropriate, should be gradual and clinically guided.
Verify your MAT coverage and start treatment.
Admissions answers 24/7. We work with commercial insurance and verify your specific coverage on the call.